# GLP-1 Treatment Duration in Type 2 Diabetes and Obesity: A 240-Day Median

A U.S. study compared duration and one-year use of GLP-1 drugs and SGLT2 inhibitors in adults with type 2 diabetes and obesity.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/two-hundred-and-forty-days-is-the-median-course
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# GLP-1 Treatment Duration in Type 2 Diabetes and Obesity: A 240-Day Median

In an insured U.S. cohort with type 2 diabetes and obesity, the median observed GLP-1 treatment duration was 240 days.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20266 min readUpdated November 2026

GLP-1 treatment in insured adults with diabetes and obesity · 240 days: median observed duration · 53% using initial treatment at one year

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

Research on [how long people stay on GLP-1 treatment](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1) uses different populations and measures. This study found a median observed duration of 240 days for GLP-1 treatment in insured adults with type 2 diabetes and obesity [\[1\]](https://buythisglp.com/research/two-hundred-and-forty-days-is-the-median-course#ref-1).

## What the cohort counted

Researchers analyzed 342,932 treatment starts among people with private or Medicare Advantage coverage (n = 335,605). About 61% of starts were GLP-1 drugs. The rest were SGLT2 inhibitors or metabolic bariatric surgery [\[1\]](https://buythisglp.com/research/two-hundred-and-forty-days-is-the-median-course#ref-1).

Median duration was 240 days for GLP-1 drugs and 254 days for SGLT2 inhibitors. At the one-year mark, 53.0% and 56.0%, respectively, were using their initial treatment. Duration and use on a given date are separate measures.

## How to read the duration figures

In a [comparison of annual plans and falling prices](https://buythisglp.com/research/glp1-falling-prices-vs-annual-plans), a billing term describes a payment commitment. This cohort study measured observed treatment patterns. Its duration estimate cannot tell someone how long their care should last.

Everyone in the cohort had both diabetes and obesity. The study does not establish treatment duration for people without diabetes or those paying entirely out of pocket.

## Frequently asked

Did half of patients stop after 240 days?

The median duration was 240 days. A separate measure found 53.0% of GLP-1 initiators using their initial treatment at the one-year mark.

## Sources

1.  \[1\] Wartko PD, Zhang R, Johnson E, Begle C, Bobb JF, Chen C (2026). Trends in utilization of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity Diabetes Research and Clinical Practice. [PMID 42624330](https://pubmed.ncbi.nlm.nih.gov/42624330/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
